Sort by
Refine Your Search
-
Category
-
Country
-
Field
-
Applications are invited for an AstraZeneca Non-Clinical PhD Studentship in Development of an Integrated Pre-Clinical Pipeline for Safety Assessment of Small Molecule and Peptide-Based
-
therapy and has supported over 100 clinical trials. In April 2020 the CBF produced ChAdOx1 nCoV-19, the UK’s first COVID-19 vaccine to enter clinical trials. Later acquired by AstraZeneca, billions of doses
-
AstraZeneca and Newcastle University , will develop predictive models for pharmaceutical manufacturing and provide access to industrial data and high-performance computing facilities. You will gain expertise
-
well as with advice from leading pharmaceutical companies such as AstraZeneca. The collaboration with industry, universities and research infrastructures ensures access to cutting-edge expertise and advanced
-
companies such as AstraZeneca. The collaboration with industry, universities, and research infrastructures ensures access to cutting-edge expertise and advanced research resources. The project includes two